Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures. A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.
Looking for a particular Freenome employee's phone or email?
The Freenome annual revenue was $132.1 million in 2026.
Riley Ennis is the Co-Founder of Freenome.
332 people are employed at Freenome.
Freenome is based in Brisbane, California.
The NAICS codes for Freenome are [62, 55, 621, 33].
The SIC codes for Freenome are [807, 80].